Michael Green, PhD

NZ born and raised researcher at @MDAndersonNews focused on the molecular basis for B-cell #lymphoma. Opinions are my own.

[AACR @AACR]

Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
https://t.co/aKGGBHdY1y
#AACRlymphoma26 @GreenLymphoLab

[AACR @AACR]

Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
https://t.co/qxGBrf0Rrw
#AACRlymphoma26

[AACR @AACR]

Deadline Extended:Submit an abstract by April 6 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML).
https://t.co/gun17Mn5NE
#AACRlymphoma26 @GreenLymphoLab

[AACR @AACR]

#AACRlymphoma26 chair Michael R. Green invites you to submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with ICML. Learn more:
https://t.co/lCqtfhJ0XS
@GreenLymphoLab

[AACR @AACR]

Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
https://t.co/bdo94vbNlz
#AACRlymphoma26 @GreenLymphoLab

[AACR @AACR]

Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
https://t.co/Ar5A9IDSA3
#AACRlymphoma26 @GreenLymphoLab

[Michael Green, PhD @GreenLymphoLab]

Abstract submissions are open for the AACR/ICML Advances in Malignant Lymphoma meeting!!
June 24-27 in Philadelphia. Please retweet.
https://t.co/Wy8BBiNuPz

[Michael Green, PhD @GreenLymphoLab]

Need PDX models for Lymphoma research? Check out our newest preprint: https://t.co/VzbcGi9zLb
We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm

[Michael Green, PhD @GreenLymphoLab]

I would prefer as an author that reviewers have the time they need to review the paper carefully. 4 days does not mean a lot in the life of a study that has taken multiple years.

[Michael Green, PhD @GreenLymphoLab]

10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.

[Michael Green, PhD @GreenLymphoLab]

This provides an initial framework for understanding spatially resolved cellular ecosystems in DLBCL, highlighting how microenvironment architecture can shape disease biology. But we are just scratching the surface.

[Michael Green, PhD @GreenLymphoLab]

Spatial profiling of diffuse large B-cell lymphoma.

I'm happy to share our latest paper, published today in @NatureGenet - a collaborative effort with @IamLinghua.
https://t.co/eznq5bcsco

[Michael Green, PhD @GreenLymphoLab]

Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.

[Pavan Bachireddy @pbachi]

Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (https://t.co/l8hxICNpJg).

👉👉https://t.co/1rFRt1qFws

[Michael Green, PhD @GreenLymphoLab]

@ESHaematology Thank you for the invitation to this wonderful conference in such a spectacular location.

[Michael Green, PhD @GreenLymphoLab]

@DelgoffeLab Never seen this before, but can't say I'm surprised. Glad you caught it - for now. On the bright side: mimicry is the sincerest form of flattery.

[Michael Green, PhD @GreenLymphoLab]

Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 months to get an accession number and even longer for data to be released is a curse to research progress. There must be another way.

[Michael Green, PhD @GreenLymphoLab]

@IamLinghua @MDAndersonNews I can't think of anyone more deserving. Congratulations!

[Michael Green, PhD @GreenLymphoLab]

Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions focused on the cutting edge of basic and translational research in Lymphoma. @AACR @icmlugano #lmsm